Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome Journal Article


Authors: Ganly, I.; Bocker, J.; Carlson, D. L.; D'Arpa, S.; Coleman, M.; Lee, N.; Pfister, D. G.; Shah, J. P.; Patel, S. G.
Article Title: Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome
Abstract: Background The objective of this study was to determine the prognostic significance of viable tumor in postchemoradiation neck dissection specimens in patients with squamous cell carcinoma of the laryngopharynx. Methods Retrospective analysis identified 181 patients treated with primary concurrent chemoradiation for carcinoma of the laryngopharynx at Memorial Sloan-Kettering Cancer Center between the years 1995 and 2005. Of these, 56 patients had a comprehensive neck dissection either as a planned or salvage procedure. Neck dissection specimens were analyzed by a single pathologist for the presence of viable tumor. The presence of viable tumor was correlated to the timing of neck dissection after chemoradiation and to tumor response. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) were determined by the Kaplan-Meier method, and correlation to tumor viability was determined with the log-rank test. Results Nineteen (33%) patients had viable tumor in their neck dissection specimens. Viable tumor was higher in patients who had a less-than-complete response to chemoradiation compared with those who had a complete response (42% vs 25%, p =.1). There was no correlation to timing of neck dissection. The 5-year OS, DSS, and RFS were significantly lower in patients who had viable tumor in their neck dissection specimens (OS 49% vs 93%, p =.0005; DSS 56% versus 93%, p =.003; RFS 40% vs 75%, p =.004). Conclusions Patients with viable tumor in postchemoradiation neck dissection specimens had a poorer outcome compared with patients with no viable tumor. © 2010 Wiley Periodicals, Inc.
Keywords: adult; cancer survival; human tissue; treatment outcome; treatment response; aged; middle aged; retrospective studies; major clinical study; overall survival; neck dissection; squamous cell carcinoma; carcinoma, squamous cell; laryngeal neoplasms; cisplatin; cancer growth; disease free survival; follow-up studies; lymphatic metastasis; retrospective study; chemoradiation; predictive value; chemoradiotherapy; hypopharynx carcinoma; kaplan-meier estimate; pharyngeal neoplasms; viable tumor; oncological parameters; tumor viability
Journal Title: Head & Neck
Volume: 33
Issue: 10
ISSN: 1043-3074
Publisher: John Wiley & Sons, Inc.  
Date Published: 2011-10-01
Start Page: 1387
End Page: 1393
Language: English
DOI: 10.1002/hed.21612
PROVIDER: scopus
PUBMED: 21928410
PMCID: PMC3772770
DOI/URL:
Notes: --- - "Export Date: 2 November 2011" - "CODEN: HEANE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Snehal G Patel
    412 Patel
  2. Diane Carlson
    52 Carlson
  3. Jennifer M Bocker
    5 Bocker
  4. Nancy Y. Lee
    871 Lee
  5. David G Pfister
    389 Pfister
  6. Ian Ganly
    430 Ganly
  7. Jatin P Shah
    721 Shah